BiotechTube
Home/Centessa Pharmaceuticals/Mary Lynne Hedley, PhD
ML

Mary Lynne Hedley, PhD

Board Director

Centessa Pharmaceuticals

Therapeutic Areas

NeuroscienceOncology

Centessa Pharmaceuticals Pipeline

DrugIndicationPhase
ORX750Narcolepsy Type 1 (NT1)Phase 2
ORX142Neurological & Neurodegenerative DisordersPreclinical / Phase 1
ORX489Neuropsychiatric DisordersPreclinical
LockBody® PlatformOncologyDiscovery

Leadership Team at Centessa Pharmaceuticals

MA
Mario Alberto Accardi, PhD
Chief Executive Officer and Director
KA
Karen Anderson
Chief People Officer
TB
Tia Bush
Chief Technology and Quality Officer
JC
John Crowley, CPA
Chief Financial Officer
RD
Raphael Deferiere, CPA
Chief Accounting Officer
IH
Iqbal Hussain
Chief Legal Officer, Chief Compliance Officer and Company Secretary
SK
Stephen Kanes, MD, PhD
Head of R&D and Chief Medical Officer
KM
Kimberly McCormick, PharmD
Senior Vice President, Regulatory Affairs and Medical Writing
KS
Kristen Sheppard, Esq
Senior Vice President, IR and Corporate Communications
CS
Charlene Stoudt
Senior Vice President, Clinical Development Operations
View full Centessa Pharmaceuticals profile